Dominic Piscitelli insider trades

Open-market stock purchases and sales by Dominic Piscitelli, Chief Financial Officer at Oric Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 24, 2017.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +146%.

Recent trades

DateStockTradeValue
Sep 28, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Sep 28, 2026ORIC Oric Pharmaceuticals, IncSold$181K
Sep 24, 2026ORIC Oric Pharmaceuticals, IncSold$1.4K
Sep 24, 2026ORIC Oric Pharmaceuticals, IncSold$6.8K
Sep 24, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Aug 26, 2026ORIC Oric Pharmaceuticals, IncSold$1.1M
Aug 26, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Aug 26, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Feb 24, 2026ORIC Oric Pharmaceuticals, IncSold$703K
Feb 24, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Dec 16, 2025ORIC Oric Pharmaceuticals, IncSold$97.1K
Dec 15, 2025ORIC Oric Pharmaceuticals, IncBought (not open market)—
Dec 15, 2025ORIC Oric Pharmaceuticals, IncBought (not open market)—
Dec 15, 2025ORIC Oric Pharmaceuticals, IncBought (not open market)—
Dec 15, 2025ORIC Oric Pharmaceuticals, IncBought (not open market)—
Oct 6, 2025ORIC Oric Pharmaceuticals, IncSold$160K
Oct 6, 2025ORIC Oric Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ORIC Oric Pharmaceuticals, Inc: 1 buy, 21 sales, last Sep 28, 2026
  • ANAB Anaptysbio Inc: 6 sales, last Feb 8, 2019

Get free alerts when Dominic Piscitelli files a new trade →